[
  {
    "objectID": "blog.html",
    "href": "blog.html",
    "title": "Blog",
    "section": "",
    "text": "No matching items"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Michael Luu, MPH",
    "section": "",
    "text": "Experience\n\nResearch Biostatistician II\nCedars-Sinai Samuel Oschin Comprehensive Cancer Center\nNov 2016 – Present\n\n\nResearch Biostatistician I\nChildren’s Hospital Los Angles, Anesthesia Critical Care Medicine\nMar 2016 – Nov 2016\n\n\nQuality Improvement Analyst\nChildren’s Hospital Los Angles, Neonatology\nJul 2015 – Nov 2016"
  },
  {
    "objectID": "projects.html",
    "href": "projects.html",
    "title": "Projects",
    "section": "",
    "text": "CHLA/USC Division of Neonatology Feeding Calculator\n\n\n\n\n\nA web based online interactive calculator built on top of the R Shiny framework. This web application implements the enteral feeding algorithm developed internally by the quality improvement team of neonatologist and nurses at CHLA by simplifying the necessity for manual calculation, and by providing an interactive environment for custom parameters and report generation. This web application has been implemented and is in currently in clinical use at Children's Hospital Los Angeles, LAC/USC Medical Center, and Hollywood Presbyterian Medical Center"
  },
  {
    "objectID": "publications.html",
    "href": "publications.html",
    "title": "Publications",
    "section": "",
    "text": "David, J., Luu, M., Lu, D., Zumsteg, Z. S., Sandler, H., & Kamrava, M. (2021). Outcomes with brachytherapy based dose escalation for gleason 8 versus 9-10 prostate cancer: An NCDB analysis. Urologic Oncology, 39(12), 829.e19–829.e26. https://doi.org/10.1016/j.urolonc.2021.04.014\n\n\nHenry, N. L., Kim, S., Hays, R. D., Diniz, M. A., Luu, M., Cecchini, R. S., Yothers, G., Rogatko, A., & Ganz, P. A. (2021). Toxicity index, patient-reported outcomes, and early discontinuation of endocrine therapy for breast cancer risk reduction in NRG oncology/NSABP b-35. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 39(34), 3800–3812. https://doi.org/10.1200/JCO.21.00910\n\n\nGresham, G., Diniz, M. A., Razaee, Z. S., Luu, M., Kim, S., Hays, R. D., Piantadosi, S., Tighiouart, M., Yothers, G., Ganz, P. A., & Rogatko, A. (2020). Evaluating treatment tolerability in cancer clinical trials using the toxicity index. Journal of the National Cancer Institute, 112(12), 1266–1274. https://doi.org/10.1093/jnci/djaa028\n\n\nLu, D. J., Luu, M., Nguyen, A. T., Scher, K. S., Clair, J. M.-S., Mita, A., Shiao, S. L., Ho, A. S., & Zumsteg, Z. S. (2019). Survival outcomes with concomitant chemoradiotherapy in older adults with oropharyngeal carcinoma in an era of increasing human papillomavirus (HPV) prevalence. Oral Oncology, 99, 104472. https://doi.org/10.1016/j.oraloncology.2019.104472\n\n\nPennington, J. D., Eilber, F. C., Eilber, F. R., Singh, A. S., Reed, J. P., Chmielowski, B., Eckardt, J. J., Bukata, S. V., Bernthal, N. M., Federman, N., Nelson, S. D., Dry, S. M., Wang, P.-C., Luu, M., Selch, M. T., Steinberg, M. L., Kalbasi, A., & Kamrava, M. (2018). Long-term outcomes with ifosfamide-based hypofractionated preoperative chemoradiotherapy for extremity soft tissue sarcomas. American Journal of Clinical Oncology, 41(12), 1154–1161. https://doi.org/10.1097/COC.0000000000000443\n\n\nZumsteg, Z. S., Luu, M., Yoshida, E. J., Kim, S., Tighiouart, M., David, J. M., Shiao, S. L., Mita, A. C., Scher, K. S., Sherman, E. J., Lee, N. Y., & Ho, A. S. (2017). Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the national cancer data base. Cancer, 123(23), 4583–4593. https://doi.org/10.1002/cncr.30933\n\n\nDiniz, M. A., Gresham, G., Kim, S., Luu, M., Henry, N. L., Tighiouart, M., Yothers, G., Ganz, P. A., & Rogatko, A. (2021). Visualizing adverse events in clinical trials using correspondence analysis with r-package visae. BMC Medical Research Methodology, 21(1), 244. https://doi.org/10.1186/s12874-021-01368-w\n\n\nLee, Y.-T., Wang, J. J., Luu, M., Noureddin, M., Kosari, K., Agopian, V. G., Rich, N. E., Lu, S. C., Tseng, H.-R., Nissen, N. N., Singal, A. G., & Yang, J. D. (2021). The mortality and overall survival trends of primary liver cancer in the united states. Journal of the National Cancer Institute, 113(11), 1531–1541. https://doi.org/10.1093/jnci/djab079\n\n\nLee, Y.-T., Wang, J. J., Luu, M., Noureddin, M., Nissen, N. N., Patel, T. C., Roberts, L. R., Singal, A. G., Gores, G. J., & Yang, J. D. (2021). Comparison of clinical features and outcomes between intrahepatic cholangiocarcinoma and hepatocellular carcinoma in the united states. Hepatology (Baltimore, Md.), 74(5), 2622–2632. https://doi.org/10.1002/hep.32007\n\n\nNguyen, A. T., Luu, M., Nguyen, V. P., Hamid, O., Faries, M. B., Gharavi, N. M., Lu, D. J., Clair, J. M.-S., Ho, A. S., & Zumsteg, Z. S. (2021). Development and validation of a modified pathologic nodal classification system for cutaneous melanoma. JAMA Surgery, 156(11), e214298. https://doi.org/10.1001/jamasurg.2021.4298\n\n\nLu, D. J., Luu, M., Nguyen, A. T., Shiao, S. L., Scher, K., Mita, A., Anderson, E., Clair, J. M.-S., Ho, A. S., & Zumsteg, Z. S. (2020). The role of concomitant chemoradiotherapy in AJCC 7th edition T1-2N1 oropharyngeal carcinoma in the human papillomavirus era. Oral Oncology, 110, 104882. https://doi.org/10.1016/j.oraloncology.2020.104882\n\n\nPatel, D. N., Luu, M., Zumsteg, Z. S., & Daskivich, T. J. (2019). Development and validation of an improved pathological nodal staging system for urothelial carcinoma of the bladder. European Urology Oncology, 2(6), 656–663. https://doi.org/10.1016/j.euo.2018.12.012\n\n\nLu, D. J., Luu, M., Mita, A., Scher, K., Shiao, S. L., Yoshida, E. P., Sittig, M. P., Clair, J. M.-S., Ho, A. S., & Zumsteg, Z. S. (2018). Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications. European Journal of Cancer (Oxford, England : 1990), 103, 195–204. https://doi.org/10.1016/j.ejca.2018.08.015\n\n\nHo, A. S., Luu, M., Shafqat, I., Clair, J. M.-S., Chen, M. M., Chen, Y., Jain, M., Ali, N., Patio, C., Filarski, C. F., Lin, D.-C., Bankston, H., Braunstein, G. D., Sacks, W. L., & Zumsteg, Z. S. (2021). Predictive impact of metastatic lymph node burden on distant metastasis across papillary thyroid cancer variants. Thyroid : Official Journal of the American Thyroid Association, 31(10), 1549–1557. https://doi.org/10.1089/thy.2021.0131\n\n\nNguyen, A. T., Luu, M., Clair, J. M.-S., Mita, A. C., Scher, K. S., Lu, D. J., Shiao, S. L., Ho, A. S., & Zumsteg, Z. S. (2020). Comparison of survival after transoral robotic surgery vs nonrobotic surgery in patients with early-stage oropharyngeal squamous cell carcinoma. JAMA Oncology, 6(10), 1555–1562. https://doi.org/10.1001/jamaoncol.2020.3172\n\n\nWalcott-Sapp, S., Srour, M. K., Lee, M., Luu, M., Amersi, F., Giuliano, A., & Chung, A. (2020). Can radiologic tumor size following neoadjuvant therapy reliably guide tissue resection in breast conserving surgery in patients with invasive breast cancer? The American Surgeon, 86(10), 1248–1253. https://doi.org/10.1177/0003134820964209\n\n\nZhao, H. H., Luu, M., Spiegel, B., & Daskivich, T. J. (2020). Correlation of online physician rating subscores and association with overall satisfaction: Observational study of 212,933 providers. Journal of Medical Internet Research, 22(10), e11258. https://doi.org/10.2196/11258\n\n\nHo, A. S., Luu, M., Zalt, C., Morris, L. G. T., Chen, I., Melany, M., Ali, N., Patio, C., Chen, Y., St-Clair, J. M., Braunstein, G. D., Sacks, W. L., & Zumsteg, Z. S. (2019). Mortality risk of nonoperative papillary thyroid carcinoma: A corollary for active surveillance. Thyroid : Official Journal of the American Thyroid Association, 29(10), 1409–1417. https://doi.org/10.1089/thy.2019.0060\n\n\nSrour, M. K., Lee, M., Walcott-Sapp, S., Luu, M., Chung, A., Giuliano, A. E., & Amersi, F. (2019). Overuse of preoperative staging of patients undergoing neoadjuvant chemotherapy for breast cancer. Annals of Surgical Oncology, 26(10), 3289–3294. https://doi.org/10.1245/s10434-019-07543-0\n\n\nSrour, M. K., Tseng, J., Luu, M., Alban, R. F., Giuliano, A. E., & Chung, A. (2019). Patterns in the use of axillary operations for patients with node-positive breast cancer after neoadjuvant chemotherapy: A national cancer database (NCDB) analysis. Annals of Surgical Oncology, 26(10), 3305–3311. https://doi.org/10.1245/s10434-019-07540-3\n\n\nPatel, D. N., Felder, S. I., Luu, M., Daskivich, T. J., Zaghiyan, K. N., & Fleshner, P. (2018). Early urinary catheter removal following pelvic colorectal surgery: A prospective, randomized, noninferiority trial. Diseases of the Colon and Rectum, 61(10), 1180–1186. https://doi.org/10.1097/DCR.0000000000001206\n\n\nDavid, J. M., Ho, A. S., Luu, M., Yoshida, E. J., Kim, S., Mita, A. C., Scher, K. S., Shiao, S. L., Tighiouart, M., & Zumsteg, Z. S. (2017). Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer. Cancer, 123(20), 3933–3942. https://doi.org/10.1002/cncr.30843\n\n\nGovalan, R., Lauzon, M., Luu, M., Ahn, J. C., Kosari, K., Todo, T., Kim, I. K., Noureddin, M., Kuo, A., Walid, A. S., Sundaram, V., Lu, S. C., Roberts, L. R., Singal, A. G., Heimbach, J. K., Agopian, V. G., Nissen, N., & Yang, J. D. (2021). Comparison of surgical resection and systemic treatment for hepatocellular carcinoma with vascular invasion: National cancer database analysis. Liver Cancer, 10(5), 407–418. https://doi.org/10.1159/000515554\n\n\nKuhlmann, P. K., Chen, M., Luu, M., Naser-Tavakolian, A., Patel, D. N., Kim, H. L., Saouaf, R., & Daskivich, T. J. (2021). Patient- and tumor-level risk factors for MRI-invisible prostate cancer. Prostate Cancer and Prostatic Diseases, 24(3), 794–801. https://doi.org/10.1038/s41391-021-00330-7\n\n\nLee, Y.-T., Wang, J. J., Luu, M., Tseng, H.-R., Rich, N. E., Lu, S. C., Nissen, N. N., Noureddin, M., Singal, A. G., & Yang, J. D. (2021). State-level HCC incidence and association with obesity and physical activity in the united states. Hepatology (Baltimore, Md.), 74(3), 1384–1394. https://doi.org/10.1002/hep.31811\n\n\nShinde, A., Jones, B., Luu, M., Li, R., Glaser, S., Massarelli, E., Freeman, M., Gernon, T., Maghami, E., Kang, R., Zumsteg, Z., Karam, S. D., & Amini, A. (2021). Factors predictive of 90-day mortality after surgical resection for oral cavity cancer: Development of a recursive partitioning analysis for risk stratification. Head & Neck, 43(9), 2731–2739. https://doi.org/10.1002/hed.26740\n\n\nYang, J. D., Luu, M., Singal, A. G., Noureddin, M., Kuo, A., Ayoub, W. S., Sundaram, V., Kotler, H., Kim, I. K., Todo, T., Voidonikolas, G., Brennan, T. V., Kosari, K., Klein, A. S., Hendifar, A., Lu, S. C., Nissen, N. N., & Gong, J. (2020). Factors associated with detection and survival of T1 hepatocellular carcinoma in the united states: National cancer database analysis. Journal of the National Comprehensive Cancer Network : JNCCN, 18(9), 1210–1220. https://doi.org/10.6004/jnccn.2020.7564\n\n\nZumsteg, Z. S., Spratt, D. E., Daskivich, T. J., Tighiouart, M., Luu, M., Rodgers, J. P., & Sandler, H. M. (2020). Effect of androgen deprivation on long-term outcomes of intermediate-risk prostate cancer stratified as favorable or unfavorable: A secondary analysis of the RTOG 9408 randomized clinical trial. JAMA Network Open, 3(9), e2015083. https://doi.org/10.1001/jamanetworkopen.2020.15083\n\n\nDaskivich, T. J., Thomas, I.-C., Luu, M., Shelton, J. B., Makarov, D. V., Skolarus, T. A., & Leppert, J. T. (2019). External validation of the prostate cancer specific comorbidity index: A claims based tool for the prediction of life expectancy in men with prostate cancer. The Journal of Urology, 202(3), 518–524. https://doi.org/10.1097/JU.0000000000000287\n\n\nDaskivich, T. J., Gale, R., Luu, M., Naser-Tavakolian, A., Venkataramana, A., Khodyakov, D., Anger, J. T., Posadas, E., Sandler, H., Spiegel, B., & Freedland, S. J. (2022). Variation in communication of competing risks of mortality in prostate cancer treatment consultations. The Journal of Urology, 208(2), 301–308. https://doi.org/10.1097/JU.0000000000002675\n\n\nYoshida, E. J., Luu, M., Freeman, M., Essner, R., Gharavi, N. M., Shiao, S. L., Clair, J. M.-S., Hamid, O., Ho, A. S., & Zumsteg, Z. S. (2020). The association between facility volume and overall survival in patients with merkel cell carcinoma. Journal of Surgical Oncology, 122(2), 254–262. https://doi.org/10.1002/jso.25931\n\n\nLu, D. J., Luu, M., Yashar, C. M., Klopp, A. H., & Kamrava, M. (2019). An evaluation of gender diversity in the american brachytherapy society. Brachytherapy, 18(6), 835–840. https://doi.org/10.1016/j.brachy.2019.07.003\n\n\nAro, K., Ho, A. S., Luu, M., Kim, S., Tighiouart, M., Clair, J. M.-S., Yoshida, E. J., Shiao, S. L., Leivo, I., & Zumsteg, Z. S. (2018). Development of a novel salivary gland cancer lymph node staging system. Cancer, 124(15), 3171–3180. https://doi.org/10.1002/cncr.31535\n\n\nLu, D. J., Luu, M., Gay, C., Nguyen, A. T., Anderson, E. M., Bernier, J., Cooper, J. S., Harari, P. M., Torres-Saavedra, P. A., Le, Q.-T., Chen, M. M., Clair, J. M.-S., Ho, A. S., & Zumsteg, Z. S. (2022). Nodal metastasis count and oncologic outcomes in head and neck cancer: A secondary analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931. International Journal of Radiation Oncology, Biology, Physics, 113(4), 787–795. https://doi.org/10.1016/j.ijrobp.2022.03.033\n\n\nNguyen, A. T., Luu, M., Nguyen, V. P., Lu, D. J., Shiao, S. L., Kamrava, M., Atkins, K. M., Mita, A. C., Scher, K. S., Spratt, D. E., Faries, M. B., Daskivich, T. J., Lin, D.-C., Chen, M. M., Clair, J. M.-S., Sandler, H. M., Ho, A. S., & Zumsteg, Z. S. (2022). Quantitative nodal burden and mortality across solid cancers. Journal of the National Cancer Institute, 114(7), 1003–1011. https://doi.org/10.1093/jnci/djac059\n\n\nVaculik, K., Luu, M., Howard, L. E., Aronson, W., Terris, M., Kane, C., Amling, C., Cooperberg, M., Freedland, S. J., & Daskivich, T. J. (2021). Time trends in use of radical prostatectomy by tumor risk and life expectancy in a national veterans affairs cohort. JAMA Network Open, 4(6), e2112214. https://doi.org/10.1001/jamanetworkopen.2021.12214\n\n\nAro, K., Ho, A. S., Luu, M., Kim, S., Tighiouart, M., Yoshida, E. J., Clair, J. M.-S., Shiao, S. L., Leivo, I., & Zumsteg, Z. S. (2019). Survival impact of adjuvant therapy in salivary gland cancers following resection and neck dissection. Otolaryngology–Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 160(6), 1048–1057. https://doi.org/10.1177/0194599819827851\n\n\nYoshida, E. J., Luu, M., David, J. M., Kim, S., Mita, A., Scher, K., Shiao, S. L., Tighiouart, M., Ho, A. S., & Zumsteg, Z. S. (2018). Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification. Head & Neck, 40(6), 1228–1236. https://doi.org/10.1002/hed.25100\n\n\nAnderson, E. M., Luu, M., Lu, D. J., Chung, E. M., & Kamrava, M. (2022). Pathologic primary tumor factors associated with risk of lymph node involvement in patients with non-endometrioid endometrial cancer. Gynecologic Oncology, 165(2), 281–286. https://doi.org/10.1016/j.ygyno.2022.01.016\n\n\nVipani, A., Lauzon, M., Luu, M., Roberts, L. R., Singal, A. G., & Yang, J. D. (2022). Decreasing trend of serum α-fetoprotein level in hepatocellular carcinoma. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 20(5), 1177–1179.e4. https://doi.org/10.1016/j.cgh.2021.08.011\n\n\nBarrios, L., Shafqat, I., Alam, U., Ali, N., Patio, C., Filarski, C. F., Bankston, H., Clair, J. M.-S., Luu, M., Zumsteg, Z. S., Adashek, K., Chen, Y., Jain, M., Braunstein, G. D., Sacks, W. L., & Ho, A. S. (2021). Incidental parathyroidectomy in thyroidectomy and central neck dissection. Surgery, 169(5), 1145–1151. https://doi.org/10.1016/j.surg.2020.11.023\n\n\nHo, A. S., Luu, M., Kim, S., Tighiouart, M., Mita, A. C., Scher, K. S., Clair, J. M.-S., Walgama, E. S., Lin, D.-C., Nguyen, A. T., & Zumsteg, Z. S. (2021). Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma. Cancer, 127(10), 1590–1597. https://doi.org/10.1002/cncr.33414\n\n\nHo, A. S., Luu, M., Barrios, L., Chen, I., Melany, M., Ali, N., Patio, C., Chen, Y., Bose, S., Fan, X., Clair, J. M.-S., Braunstein, G. D., Sacks, W. L., & Zumsteg, Z. S. (2020). Incidence and mortality risk spectrum across aggressive variants of papillary thyroid carcinoma. JAMA Oncology, 6(5), 706–713. https://doi.org/10.1001/jamaoncol.2019.6851\n\n\nKaisey, M., Solomon, A. J., Luu, M., Giesser, B. S., & Sicotte, N. L. (2019). Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers. Multiple Sclerosis and Related Disorders, 30, 51–56. https://doi.org/10.1016/j.msard.2019.01.048\n\n\nDaskivich, T., Luu, M., Noah, B., Fuller, G., Anger, J., & Spiegel, B. (2018). Differences in online consumer ratings of health care providers across medical, surgical, and allied health specialties: Observational study of 212,933 providers. Journal of Medical Internet Research, 20(5), e176. https://doi.org/10.2196/jmir.9160\n\n\nAhn, J. C., Lauzon, M., Luu, M., Noureddin, M., Ayoub, W., Kuo, A., Sundaram, V., Kosari, K., Nissen, N., Gong, J., Hendifar, A., Roberts, L. R., Abou-Alfa, G. K., Singal, A. G., & Yang, J. D. (2022). Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the united states. Hepatology (Baltimore, Md.). https://doi.org/10.1002/hep.32527\n\n\nKuhlmann, P. K., Chen, M., Luu, M., Naser-Tavakolian, A., Kim, H. L., Saouaf, R., & Daskivich, T. J. (2022). Predictors of disparity between targeted and in-zone systematic cores during transrectal MR/US-fusion prostate biopsy. Urologic Oncology, 40(4), 162.e1–162.e7. https://doi.org/10.1016/j.urolonc.2021.12.016\n\n\nAhn, J. C., Lauzon, M., Luu, M., Friedman, M. L., Kosari, K., Nissen, N., Lu, S. C., Roberts, L. R., Singal, A. G., & Yang, J. D. (2021). Transarterial radioembolization versus systemic treatment for hepatocellular carcinoma with macrovascular invasion: Analysis of the US national cancer database. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.121.261954\n\n\nAnderson, E. M., Luu, M., Balzer, B. L., Scher, K. S., Mita, A. C., Lu, D. J., Shiao, S. L., Clair, J. M.-S., Ho, A. S., & Zumsteg, Z. S. (2021). Variations in the association of grade with survival across the head and neck cancer landscape. Head & Neck, 43(4), 1105–1115. https://doi.org/10.1002/hed.26566\n\n\nSrour, M. K., Lee, M., Wolcott-Sapp, S., Luu, M., Chung, A., Giuliano, A. E., & Amersi, F. (2021). Incidental radiologic findings in breast cancer patients who undergo staging prior to neo-adjuvant chemotherapy. The Breast Journal, 27(4), 345–351. https://doi.org/10.1111/tbj.14172\n\n\nGuan, M., He, I., Luu, M., David, J., Gong, J., Placencio-Hickok, V. R., Reznik, R. S., Tuli, R., & Hendifar, A. E. (2019). Palliative radiation therapy for bone metastases in neuroendocrine neoplasms. Advances in Radiation Oncology, 4(3), 513–519. https://doi.org/10.1016/j.adro.2019.03.014\n\n\nDaskivich, T. J., Luu, M., Freedland, S. J., Sandler, H., Spratt, D. E., & Zumsteg, Z. S. (2022). Development and validation of an improved pathological nodal staging system in men with prostate cancer. The Journal of Urology, 207(3), 581–591. https://doi.org/10.1097/JU.0000000000002256\n\n\nHo, A. S., Luu, M., Barrios, L., Balzer, B. L., Bose, S., Fan, X., Walgama, E., Clair, J. M.-S., Alam, U., Shafqat, I., Lin, D.-C., Chen, Y., Van Eyk, J. E., Maghami, E. G., Braunstein, G. D., Sacks, W. L., & Zumsteg, Z. S. (2021). Prognostic impact of histologic grade for papillary thyroid carcinoma. Annals of Surgical Oncology, 28(3), 1731–1739. https://doi.org/10.1245/s10434-020-09023-2\n\n\nMarkman, J. L., Porritt, R. A., Wakita, D., Lane, M. E., Martinon, D., Rivas, M. N., Luu, M., Posadas, E. M., Crother, T. R., & Arditi, M. (2020). Loss of testosterone impairs anti-tumor neutrophil function. Nature Communications, 11(1), 1613. https://doi.org/10.1038/s41467-020-15397-4\n\n\nMarcrom, S. R., Kahn, J. M., Colbert, L. E., Freese, C. M., Doke, K. N., Yang, J. C., Yashar, C. M., Luu, M., & Kamrava, M. (2019). Brachytherapy training survey of radiation oncology residents. International Journal of Radiation Oncology, Biology, Physics, 103(3), 557–560. https://doi.org/10.1016/j.ijrobp.2018.10.023\n\n\nKaisey, M., Solomon, A. J., Guerrero, B. L., Renner, B., Fan, Z., Ayala, N., Luu, M., Diniz, M. A., Sati, P., & Sicotte, N. L. (2021). Preventing multiple sclerosis misdiagnosis using the \"central vein sign\": A real-world study. Multiple Sclerosis and Related Disorders, 48, 102671. https://doi.org/10.1016/j.msard.2020.102671\n\n\nNguyen, A. T., Luu, M., Lu, D. J., Hamid, O., Clair, J. M.-S., Faries, M. B., Gharavi, N. M., Ho, A. S., & Zumsteg, Z. S. (2021). Quantitative metastatic lymph node burden and survival in merkel cell carcinoma. Journal of the American Academy of Dermatology, 84(2), 312–320. https://doi.org/10.1016/j.jaad.2019.12.072\n\n\nTam, M., Luu, M., Barker, C. A., Gharavi, N. M., Hamid, O., Shiao, S. L., Nguyen, A. T., Lu, D. J., Ho, A. S., & Zumsteg, Z. S. (2021). Improved survival in women versus men with merkel cell carcinoma. Journal of the American Academy of Dermatology, 84(2), 321–329. https://doi.org/10.1016/j.jaad.2020.02.034\n\n\nDaskivich, T. J., Houman, J., Lopez, M., Luu, M., Fleshner, P., Zaghiyan, K., Cunneen, S., Burch, M., Walsh, C., Paiement, G., Kremen, T., Soukiasian, H., Spitzer, A., Jackson, T., Kim, H. L., Li, A., & Spiegel, B. (2019). Association of wearable activity monitors with assessment of daily ambulation and length of stay among patients undergoing major surgery. JAMA Network Open, 2(2), e187673. https://doi.org/10.1001/jamanetworkopen.2018.7673\n\n\nMahrer, N. E., Gold, J. I., Luu, M., & Herman, P. M. (2018). A cost-analysis of an interdisciplinary pediatric chronic pain clinic. The Journal of Pain, 19(2), 158–165. https://doi.org/10.1016/j.jpain.2017.09.008\n\n\nYoshida, E. J., Luu, M., David, J. M., Kim, S., Mita, A., Scher, K., Shiao, S. L., Tighiouart, M., Lee, N. Y., Ho, A. S., & Zumsteg, Z. S. (2018). Facility volume and survival in nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics, 100(2), 408–417. https://doi.org/10.1016/j.ijrobp.2017.09.038\n\n\nDaskivich, T. J., Gale, R., Luu, M., Khodyakov, D., Anger, J. T., Freedland, S. J., & Spiegel, B. (2022). Patient preferences for communication of life expectancy in prostate cancer treatment consultations. JAMA Surgery, 157(1), 70–72. https://doi.org/10.1001/jamasurg.2021.5803\n\n\nGovalan, R., Luu, M., Lauzon, M., Kosari, K., Ahn, J. C., Rich, N. E., Nissen, N., Roberts, L. R., Singal, A. G., & Yang, J. D. (2022). Therapeutic underuse and delay in hepatocellular carcinoma: Prevalence, associated factors, and clinical impact. Hepatology Communications, 6(1), 223–236. https://doi.org/10.1002/hep4.1795\n\n\nSittig, M. P., Luu, M., Yoshida, E. J., Scher, K., Mita, A., Shiao, S. L., Lu, D. J., Clair, J. M.-S., Ho, A. S., & Zumsteg, Z. S. (2020). Impact of insurance on survival in patients < 65 with head & neck cancer treated with radiotherapy. Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 45(1), 63–72. https://doi.org/10.1111/coa.13467\n\n\nYoshida, E. J., Luu, M., Clair, J. M.-S., Mita, A. C., Scher, K. S., Lu, D. J., Nguyen, A. T., Shiao, S. L., Ho, A. S., & Zumsteg, Z. S. (2020). Stage i HPV-positive oropharyngeal cancer: Should all patients receive similar treatments? Cancer, 126(1), 58–66. https://doi.org/10.1002/cncr.32501"
  }
]